Health

AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study

A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.

The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against imicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.

For all the latest headlines follow our Google News channel online or via the app.

After a three-dose course of the vaccine, neutralizing levels against omicron were similar to those against the virus’s delta variant after two doses, the company added.

The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.

Pfizer pill becomes first US-authorized home COVID-19 treatment

No country can boost its way out of pandemic: WHO chief

Health

World News in Brief: Vaccine ‘patches’ trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation

Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots.

Health

No sign yet of H5N1 bird flu spreading between humans, says WHO chief

The H5N1 avian influenza virus has so far shown no signs of adapting to allow human to human transmission, the UN health agency said on Wednesday, urging continued surveillance.

Health

Patients in Rafah ‘afraid to seek services’, WHO reports

The World Health Organization (WHO) has taken “crucial steps” in the event of a large-scale Israeli military operation in Rafah, Dr. Ahmed Dahir, Team Lead of its office in Gaza, told UN News on Tuesday.